Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada

Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Dec 8, 2013

Keywords

ClinConnect Summary

This clinical trial is focused on familial hypercholesterolemia (FH), a genetic condition that leads to high cholesterol levels and increases the risk of heart disease at an early age. The trial aims to create a registry of people with FH across Canada to better understand the condition and improve patient care. By gathering health information and biological samples from participants, the registry will help doctors and researchers study FH more effectively and provide better treatment options.

To be eligible for this study, participants should have a diagnosis of FH, which may be indicated by a family history of high cholesterol or heart disease, or certain physical signs like growths on tendons or fatty deposits in the eyes. There are no specific exclusions, meaning anyone who meets the criteria can participate. Those involved can expect to provide health information and samples while contributing to a valuable resource that could lead to new insights and treatments for FH in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Clinical diagnostic criteria for FH, which are:
• • Family and/or personal history of high cholesterol
• • Family and/or personal history of heart disease
• • Abnormal growth on tendons, accumulation of fatty material in the eye
• • Family history of FH
• • Severe disorder of cholesterol and other lipids in the blood
• Exclusion Criteria:
• • No exclusion criterion